ITIC:NASDAQInvestors Title Company Analysis
Data as of 2026-08-08 - not real-time
$289.84
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Investors Title Company is priced at $289.84 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it gained 9.3%. Relative strength is 57.4 — neutral — and the MACD signal is bearish. Watch $269.46 as support and $297.31 as the nearer resistance level.
The shares look fair, trading on 13.8 times earnings below a sector average of 16.9. Revenue is growing at 17.5% on a 13.8% profit margin. The 0.63% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 26.8%, a beta of 0.29 and a maximum drawdown of 26.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
The shares look fair, trading on 13.8 times earnings below a sector average of 16.9. Revenue is growing at 17.5% on a 13.8% profit margin. The 0.63% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 26.8%, a beta of 0.29 and a maximum drawdown of 26.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 5/10.
Top Market Events
The Joplin Globe2dInvestors Title Company Announces Second Quarter 2026 ResultsInvestors Title Company Nasdaq: ITIC...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 252.61
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 13.8 versus sector average of 16.9
- Trading above the 200-day average of 252.61
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 13.8 versus sector average of 16.9
- Revenue growth of +17.5%
- Dividend yield of 0.63%
Key Metrics & Analysis
Financial Health
Revenue Growth17.50%
Profit Margin13.80%
P/E Ratio13.8
ROE14.63%
ROA8.92%
Debt/Equity3.04
P/B Ratio2.0
Industry P/E16.9
Technical Analysis
TrendBullish
RSI57.4
Support$269.46
Resistance$297.31
MA 20$286.36
MA 50$269.38
MA 200$252.61
MACDBearish
VolumeIncreasing
Fear & Greed Index94.82
Valuation
GradeFair
TypeBlend
Dividend Yield0.63%
Risk Assessment
Beta0.29
Volatility26.77%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.